| Telomerase activation by genomic rearrangements in high-risk neuroblastoma M Peifer, F Hertwig, F Roels, D Dreidax, M Gartlgruber, R Menon, ... Nature 526 (7575), 700-704, 2015 | 605 | 2015 |
| A mechanistic classification of clinical phenotypes in neuroblastoma S Ackermann, M Cartolano, B Hero, A Welte, Y Kahlert, A Roderwieser, ... Science 362 (6419), 1165-1170, 2018 | 276 | 2018 |
| Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma F Ikram, S Ackermann, Y Kahlert, R Volland, F Roels, A Engesser, ... Molecular oncology 10 (2), 344-359, 2016 | 42 | 2016 |
| Fibroblast growth factor receptors as therapeutic targets in neuroblastoma E Arnz, F Hertwig, A Krämer, F Ikram, F Roels, H Kocak, A Engesser, ... Klinische Pädiatrie 226 (03), A22, 2014 | 2 | 2014 |
| 409 Transcription factor activating protein 2 beta (TFAP2B) mediates neuronal differentiation in neuroblastoma F Ikram, S Ackermann, F Roels, R Volland, B Hero, F Hertwig, H Kocak, ... European Journal of Cancer, 130-131, 2014 | 1 | 2014 |
| Managing an unwelcome effect HJ Smith Science 362 (6419), 1125-1126, 2018 | | 2018 |
| Establishing a model for functional characterisation of somatically mutated genes in neuroblastoma A Krämer, S Ackermann, F Roels, H Kocak, F Hertwig, Y Kahlert, ... Klinische Pädiatrie 226 (03), A27, 2014 | | 2014 |
